Evaluation of MGAT5 expression and its β1,6-GlcNAc branched glycan products has been well described in human multiple sclerosis (MS) and experimental autoimmune encephalitis (EAE) in mice. This evidence concerns the gene MGAT5 and myeloid sarcoma.